ARCUATE Trademark

Trademark Overview


On Tuesday, October 25, 2005, a trademark application was filed for ARCUATE with the United States Patent and Trademark Office. The USPTO has given the ARCUATE trademark a serial number of 78739829. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, April 4, 2007. This trademark is owned by Arcuate Therapeutics, Inc.. The ARCUATE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for treating metabolic disorders, namely, diabetes and obesity; pharmaceutical preparations for the regulation of food intake; pharmaceutical preparations for the regulation of glucose production; pharmaceutical preparations used to modulate long-chain fatty acyl-CoA levels in the hypothalamus; pharmaceutical preparations used to agonize KATP channels in the hypothalamus; pharmaceutical preparations used to inhibit pyruvate dehydrogenase kinase (PDHK) in the hypothalamus; pharmaceutical preparations used to effect amino acid and other analyte sensing in the hypothalamus for the treatment of obesity and diabetes
arcuate

General Information


Serial Number78739829
Word MarkARCUATE
Filing DateTuesday, October 25, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, April 4, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, preparations for treating metabolic disorders, namely, diabetes and obesity; pharmaceutical preparations for the regulation of food intake; pharmaceutical preparations for the regulation of glucose production; pharmaceutical preparations used to modulate long-chain fatty acyl-CoA levels in the hypothalamus; pharmaceutical preparations used to agonize KATP channels in the hypothalamus; pharmaceutical preparations used to inhibit pyruvate dehydrogenase kinase (PDHK) in the hypothalamus; pharmaceutical preparations used to effect amino acid and other analyte sensing in the hypothalamus for the treatment of obesity and diabetes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 31, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArcuate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27609

Party NameArcuate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27609

Trademark Events


Event DateEvent Description
Thursday, June 21, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, June 20, 2007ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 3, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2006PUBLISHED FOR OPPOSITION
Wednesday, June 21, 2006NOTICE OF PUBLICATION
Monday, May 22, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 5, 2006ASSIGNED TO LIE
Friday, April 28, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 27, 2006ASSIGNED TO EXAMINER
Monday, October 31, 2005NEW APPLICATION ENTERED IN TRAM